Related Experiment Video
Updated: May 15, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Outbreak of multidrug-resistant CTX-M-15-producing Enterobacter cloacae in a neonatal intensive care unit
Jesús Oteo1, Emilia Cercenado2,3, Ana Vindel1
1Antibiotic Laboratory, Department of Bacteriology, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Insights
Newborns are rarely infected by extended-spectrum beta-lactamase (ESBL) producers. However, a neonatal intensive care unit outbreak involved 14 newborns with CTX-M-15-producing Enterobacter cloacae, highlighting a critical issue.
Area of Science:
- Neonatal intensive care unit epidemiology
- Antimicrobial resistance
- Clinical microbiology
Background:
- Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are uncommon causes of newborn infections.
- Enterobacter cloacae is a potential nosocomial pathogen.
Observation:
- A neonatal intensive care unit (NICU) reported 14 cases of infection or colonization by CTX-M-15-producing Enterobacter cloacae.
- All seven infected neonates had significant underlying medical conditions.
- Five infected neonates were successfully treated with meropenem; one untreated neonate died.
Findings:
- CTX-M-15-producing Enterobacter cloacae can cause severe infections in vulnerable newborns.
- Multidrug-resistant ESBL-producing Enterobacter cloacae represent a significant threat in neonatal populations.
Implications:
- This highlights the critical clinical and epidemiological challenge posed by multidrug-resistant pathogens in neonatal intensive care units.
- Effective treatment strategies, such as meropenem, are crucial for managing these infections.
- Enhanced infection control measures are necessary to prevent outbreaks of resistant bacteria in NICUs.
Abstract:
Newborns are rarely infected by extended-spectrum β-lactamase (ESBL)-producing members of the Enterobacteriaceae. In a neonatal intensive care unit, 14 newborns were infected or colonized by CTX-M-15-producing Enterobacter cloacae. All seven infected patients had underlying medical conditions, and five of them were treated successfully with meropenem, whilst one untreated patient died. Paediatric infections caused by multidrug-resistant ESBL-producing Enterobacter cloacae constitute a critical clinical and epidemiological issue.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Bacterial Gastroenteritis
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance

